Expanding high risk population drives European hepatitis B and C diagnostics market, finds Frost & Sullivan
Low turnaround time and ease-of-use boosts use of rapid hepatitis assays in laboratories and point-of-care settings
13-Mar-2013 -
In recent years, the prevalence of hepatitis C has increased among high risk sub-group populations, including immigrants from areas where the disease is endemic, injecting drug users (IDUs) and patients co-infected with HIV.
“Overall, the incidence of hepatitis C among IDUs in Europe is estimated ...
AIDS
Frost & Sullivan
hepatitis B
+2